Table 2.

Administered SCIG doses and serum IgG trough levels during the efficacy evaluation period

	European/Brazilian study (n = 15)	North American study (n = 5)
SCIG dose
Median (range) (mg/kg/week)	89 (61–128)	144 (92–326)
Median % of previous IVIG dose	97%	126%
IgG trough level
Median (range) (g/l)	8·5 (6·5–16·6)	11·5 (6·2–18·1)
Median % of IgG trough level during previous IVIG treatment	116%	113%

Analysed variables were first aggregated to medians for each patient. n: number of patients with available data; SCIG: subcutaneous immunoglobulin; IVIG: intravenous immunoglobulin; Ig: immunoglobulin.